Emergent BioSolutions Inc. — Director's Dealing 2018

Aug 23, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-08-03

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-03	Common Stock	M	100	$14.71	Acquired	21063	Direct
2018-08-03	Common Stock	S	100	$60.00	Disposed	20963	Direct
2018-08-21	Common Stock	M	7793	$14.71	Acquired	28756	Direct
2018-08-21	Common Stock	S	7793	$60.0166	Disposed	20963	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-03	Stock Option (Right to Buy)	$14.71	M	100	Disposed	2020-05-19	Common Stock (100)	Direct
2018-08-21	Stock Option (Right to Bury)	$14.71	M	7793	Disposed	2020-05-19	Common Stock (7793)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.

F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to 60.05, inclusive.

F3: Consists of an option granted under the company's stock incentive plan as amended and restated.

F4: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.